China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.50+0.02 (+4.17%)
Close on Nov 17, 2026Market cap $21.51MP/E –Yield –
China Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
China Pharma's pe ratio was 41.5× on Jul 31, 2013, against 9.4× a year earlier. Over the last 3 years it ranged from 8.8× to 51.3×, with a median of 18.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2013 | Jul 31, 2013 | 41.5× | +32.6 |
| 2012 | Dec 31, 2012 | 8.9× | −5.7 |
| 2011 | Dec 30, 2011 | 14.6× | – |
See a number that looks wrong?